526PPHASE II STUDY OF COMBINED CHEMOTHERAPY WITH 5-WEEK CYCLES OF S-1 AND CPT-11 (IRIS) PLUS BEVACIZUMAB IN PATIENTS WITH METASTATIC COLON CANCER
Abstract Aim: Combined chemotherapy with S-1 and irinotecan (IRIS) for metastatic colorectal cancer has been reported to be effective and safe. However, there are only a few studies on the effects of adding bevacizumab to the IRIS. We conducted a clinical study to evaluate the efficacy and safety of...
Gespeichert in:
Veröffentlicht in: | Annals of oncology 2014-09, Vol.25 (suppl_4), p.iv179-iv179 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!